This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medbox Files Form 10 With SEC





HOLLYWOOD, Calif., April 10, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) ( www.medboxinc.com), announced it has filed its Form 10 to become a fully reporting public company with the Securities and Exchange Commission.  

One of the many highlights of the filing is a licensing agreement that illustrates the devotion the company's patent holding affiliate, PVM International, Inc., has towards the company's shareholders. The agreement calls for exclusive rights to the issued patent as well as 4 other pending patents at a rate of $1 per year, per issued and pending patent, for the duration of the patents.

"We are fortunate to have such strong leadership in key positions here at Medbox and our affiliate companies," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "The last few weeks have been a test of our resolve, but we have demonstrated that we are up for the challenge in running a public company and enjoy being a leader in shaping new industries." 

The Form 10 document, financial statements, auditor's footnotes, and opinion letter can be found at the following link on the company's website:  http://www.thedispensingsolution.com/wp-content/uploads/2013/04/Form-10-PDF1.pdf

The company retracts the release last week announcing the completion of the audit process. However, the company has engaged a replacement PCAOB registered firm to complete any and all filings for the company on a going forward basis.



About Medbox, Inc:  Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,144.14 +132.20 0.73%
S&P 500 2,113.77 +4.17 0.20%
NASDAQ 5,093.2550 +16.7310 0.33%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs